We need your support to keep TheyWorkForYou running and make sure people across the UK can continue to hold their elected representatives to account.

Donate to our crowdfunder

Haemophilia: Medical Treatments

Department of Health and Social Care written question – answered on 18th October 2018.

Alert me about debates like this

Photo of Diana R. Johnson Diana R. Johnson Labour, Kingston upon Hull North

To ask the Secretary of State for Health and Social Care, if he will publish the timescale for the completion of the tenders for (a) Factor VIII and (b) Factor IX blood products.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

The current Commercial Medicines Unit (CMU) framework agreements that cover the stated products run from the following dates and have the following expiry dates and extension options:

- NHS Framework Agreement for the Supply of Recombinant Factor VIII products for the treatment of bleeding disorders – commencement date 1 February 2018 / expiry date 31 January 2019 with options to extend up to a further 17 months. The CMU are working towards extending this framework agreement;

- NHS National Framework Agreement for the supply of Human Cell Line Recombinant Factor VIII products for the treatment of bleeding disorders – commencement date 1 July 2016 / expiry date 31 January 2019 with options to extend up to a further 17 months. The CMU are working towards extending this framework agreement;

- NHS National Framework Agreement for the supply of Recombinant Factor IX Blood Clotting Factors – commencement date 1 September 2016 / expiry date 28 February 2019 with options to extend up to a further 18 months. This framework is due to be re-tendered with the anticipated publication date of the OJEU Notice being early November 2018, tender timescales will be dependent on when this notice is issued; and

- NHS Framework Agreement for the supply of products for the treatment of bleeding disorders – commencement date 1 July 2018 / expiry date 30 June 2019 with options to extend up to a further 36 months.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.